Washington Trust CO Sarepta Therapeutics, Inc. Transaction History
Washington Trust CO
- $2.83 Billion
- Q3 2024
A detailed history of Washington Trust CO transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Washington Trust CO holds 17 shares of SRPT stock, worth $1,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 17
-0.0%
Holding current value
$1,777
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
532Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$937 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$654 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$456 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$446 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.15B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...